Seeing Is Believing
Currently out of the existing stock ratings of Ken Cacciatore, 91 are a BUY (68.94%), 38 are a HOLD (28.79%), 3 are a SELL (2.27%).
Analyst Ken Cacciatore, currently employed carries an average stock price target met ratio of 35.99% that have a potential upside of 30.62% achieved within 99 days. Previously, Ken Cacciatore worked at COWEN.
Ken Cacciatore’s has documented 264 price targets and ratings displayed on 24 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BHVN, Biohaven Pharmaceutical Holding Co Ltd at 15-Nov-2023.
Analyst best performing recommendations are on AMRN (AMARIN PLC).
The best stock recommendation documented was for AMRN (AMARIN PLC) at 3/30/2020. The price target of $8 was fulfilled within 1 day with a profit of $5.58 (41.09%) receiving and performance score of 410.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3 years 1 months 8 days ago
(17-Nov-2021)
0/1 (0%)
$34.88 (99.32%)
Hold
$14
3 years 2 months 12 days ago
(13-Oct-2021)
3/7 (42.86%)
$9.25 (194.74%)
87
Hold
$7
$-1.22 (-14.84%)
$7
3 years 2 months 13 days ago
(12-Oct-2021)
3/8 (37.5%)
$-1.08 (-13.37%)
124
Buy
$9.1
$0.88 (10.71%)
$12
3 years 2 months 13 days ago
(12-Oct-2021)
0/7 (0%)
$1.02 (12.62%)
Buy
$6
$-2.22 (-27.01%)
$20
3 years 2 months 14 days ago
(12-Oct-2021)
0/2 (0%)
$3.2 (23.94%)
What Year was the first public recommendation made by Ken Cacciatore?